Live feed
Filing
SC 13G/A
SC 13G/A0000902219-16-001131·Ultragenyx Pharmaceutical Inc.
Schedule 13G ownership disclosure
Ultragenyx Pharmaceutical Inc
Security class unavailable · CUSIP: 90400D108
Event date: 2016-02-29
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 4,050,477
- Percent of class
- 10.3900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902219-16-001131
- Form type
- SC 13G/A
- Filer
- Ultragenyx Pharmaceutical Inc.
- CIK
- CIK 1515673
- Filed
- Mar 10, 2016
- Reporting period
- Feb 29, 2016
- Description
- Schedule 13G beneficial ownership